/
CHE
$462.50+$2.60 (+0.57%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$6.1B
13M shares
52-week range
$365.21 – $508.71
68% from low
Sector
SERVICES-HOME HEALTH CARE SERVICES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-19.97
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.78B | $1.94B | $2.08B | $2.14B | $2.13B | $2.26B | $2.43B | $2.53B |
| Cost of revenue | $1.23B | $1.32B | $1.38B | $1.37B | $1.37B | $1.47B | $1.58B | $1.77B |
| Gross profit | $555.0M | $617.4M | $701.4M | $769.8M | $765.1M | $798.8M | $854.3M | $758.3M |
| Gross margin | 31.1% | 31.8% | 33.7% | 36.0% | 35.8% | 35.3% | 35.1% | 30.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $243.6M | $257.4M | $389.7M | $343.0M | $343.5M | $340.6M | $366.5M | $338.2M |
| EBITDA | $283.5M | $311.3M | $454.9M | $411.2M | $393.4M | $414.3M | $464.3M | $422.4M |
| Net income | $205.5M | $219.9M | $319.5M | $268.6M | $249.6M | $272.5M | $302.0M | $265.2M |
| Net margin | 11.5% | 11.3% | 15.4% | 12.6% | 11.7% | 12.0% | 12.4% | 10.5% |
| EPS (diluted) | 12.23 | 13.31 | 19.48 | 16.85 | 16.53 | 17.93 | 19.89 | 18.42 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.7B | $24.34 | $23.93–$24.75 | 2 |
| 2027 | $2.9B | $26.88 | $26.09–$27.67 | 2 |
| 2028 | $3.0B | $28.85 | $28.72–$28.96 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$632.05
Price
$462.50
Implied upside
+37%
Peer comparison
Chemed Corporation
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
www.chemed.com- Employees
- 15,811
- IPO / List date
- Jun 1, 1972
- HQ
- CINCINNATI, OH
Held by traders on TradeandTell
No one on the platform currently holds CHE.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 12,340 | $4.7M |
| Bridgewater Associatesas of 2026-03-31 | 5,062 | $1.9M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 0.52% ($2.40/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-28 | $0.6000 | 2026-06-16 |
| 2026-02-23 | $0.6000 | 2026-03-13 |
| 2025-11-17 | $0.6000 | 2025-12-05 |
| 2025-08-11 | $0.6000 | 2025-08-29 |
| 2025-05-29 | $0.5000 | 2025-06-17 |
| 2025-02-24 | $0.5000 | 2025-03-14 |
| 2024-11-18 | $0.5000 | 2024-12-06 |
| 2024-08-12 | $0.5000 | 2024-08-30 |
| 2024-05-30 | $0.4000 | 2024-06-18 |
| 2024-02-23 | $0.4000 | 2024-03-15 |
Recent trades on TradeandTell
No one on the platform has traded CHE yet.
